The emerging approach of the medication represents a significant development in the care of type 2 diabetes. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide949157.loginblogin.com/50222513/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment